- Report
- March 2024
- 190 Pages
Global
From €3262EUR$3,374USD£2,802GBP
€3624EUR$3,749USD£3,113GBP
- Report
- October 2023
- 177 Pages
Global
From €4737EUR$4,900USD£4,069GBP
- Report
- March 2024
- 200 Pages
Global
From €4012EUR$4,150USD£3,446GBP
- Report
- January 2024
- 200 Pages
Global
From €4012EUR$4,150USD£3,446GBP
- Report
- February 2024
- 80 Pages
Latin America
From €4592EUR$4,750USD£3,945GBP
- Report
- August 2023
- 336 Pages
Global
From €5317EUR$5,500USD£4,567GBP
- Report
- February 2024
- 150 Pages
Global
From €4592EUR$4,750USD£3,945GBP
- Report
- February 2024
- 150 Pages
Global
From €4592EUR$4,750USD£3,945GBP
- Report
- February 2024
- 126 Pages
Global
From €4592EUR$4,750USD£3,945GBP
- Clinical Trials
- April 2024
- 40 Pages
Global
From €1208EUR$1,250USD£1,038GBP
- Clinical Trials
- April 2024
- 200 Pages
Global
From €4834EUR$5,000USD£4,152GBP
- Drug Pipelines
- April 2024
- 220 Pages
Global
From €2900EUR$3,000USD£2,491GBP
- Report
- August 2023
- 145 Pages
Global
From €3045EUR$3,150USD£2,616GBP
- Report
- May 2023
- 172 Pages
Global
From €2417EUR$2,500USD£2,076GBP
- Report
- February 2024
- 70 Pages
Europe
From €4592EUR$4,750USD£3,945GBP
- Report
- February 2024
- 70 Pages
Asia Pacific
From €4592EUR$4,750USD£3,945GBP
- Report
- February 2024
- 90 Pages
Asia Pacific
From €4592EUR$4,750USD£3,945GBP
- Report
- February 2024
- 70 Pages
North America
From €4592EUR$4,750USD£3,945GBP
- Report
- February 2024
- 70 Pages
United States
From €4592EUR$4,750USD£3,945GBP
- Report
- February 2024
- 70 Pages
Latin America
From €4592EUR$4,750USD£3,945GBP
The Antidiabetic market is a subset of Endocrine and Metabolic Disorders Drugs, which are used to treat a variety of conditions related to hormones and metabolism. Antidiabetic drugs are used to treat diabetes, a chronic condition in which the body does not produce or properly use insulin. These drugs can help control blood sugar levels, reduce the risk of complications, and improve quality of life. Common antidiabetic drugs include insulin, sulfonylureas, biguanides, thiazolidinediones, and meglitinides.
Some companies in the Antidiabetic market include Novo Nordisk, Sanofi, Eli Lilly, Merck, and Boehringer Ingelheim. These companies produce a variety of antidiabetic drugs, including insulin, oral medications, and combination products. Show Less Read more